| Aqualift
AQUALIFT TM
Product Characteristic
* AQUALIFTTM is a highly elastic and biocompatible hydrogel, its properties and chemical structure optimally agree with the human body inner medium and with the intercellular substance of the skin dermal layer, which noticeably minimizes post operation complication and other aftereffects.
Basic Properties
* AQUALIFTTM is a positively charged electrolyte that does not affect electric conductivity within the tissues while blocking negatively charged free radicals of the oxygen active components, which enhances body tissues resistance to the aging processes.
* AQUALIFTTM increases electric potential of the surrounding tissues, normalizes microcirculation within the zone of its introduction, thanks to its positive charge it attracts the dissolved negatively charged molecules of the extracellular matrix collagen, elastin, fibroectin, glucozaminglicanes.
* AQUALIFTTM is a highly elastic hydrogel, it can be injected using thin needles. When introduced in small volumes it does not require preliminary anesthetization of the injection zone.
* AQUALIFTTM is inert material that does not react with the previously injected fillers, which allows its multiple introduction into the same anatomic zone.
* AQUALIFT TM displays subacid properties.
* AQUALIFT TM does not cause any inflammations of the tissues, and it does not migrate from the zone of its injection.
* AQUALIFT TM does not exert any irritating impact, any allergic reaction, or any incompatibility, since it does not contain initiators of immune reactions.
Composition
* Cationic copolymer of polyamide 2 %.
* Physiological solution, 0.9 % of sodium chloride,-98 %
Indication for Application
* Contour plastics of facial soft tissues.
* Correction of age-specific changes in facial soft tissues.
* Change of shape and volume of the lips.
* Correction of asymmetry in facial soft tissues.
* Correction of posttraumatic, postsurgical, congenital defects and deformities of the facial soft tissues, beginning from early child age.
* Correction of atrophic changes in facial soft tissues.
Contraindication for Application
* Acute and chronic specific and non-specific inflammatory diseases.
* Infectious-allergic diseases.
* Diseases of skin and subcutaneous cellular tissue within the zone of injection.
* Diseases of the blood vessels of various etiology within the zone of injection.
* Acute infectious diseases of specific and nonspecific etiology.
* Chronic infectious diseases at the stage of stable remission or exacerbation.
* Decompensated stages in functional condition of the organs systems.
* Compensated stages in the course of general somatic diseases.
| 
